Ken Griffin Acer Therapeutics Inc. Call Options Transaction History

Citadel Advisors LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	SELL	$0.75 - $1.14 $225 - $341	-300 Reduced 15.0%	1,700 $1,000
Q1 2023 May 15, 2023	SELL	$0.67 - $3.05 $26,264 - $119,560	-39,200 Reduced 95.15%	2,000 $1,000
Q4 2022 Feb 14, 2023	BUY	$1.13 - $4.15 $1,468 - $5,395	1,300 Added 3.26%	41,200 $103,000
Q3 2022 Nov 14, 2022	SELL	$1.28 - $1.6 $18,688 - $23,360	-14,600 Reduced 26.79%	39,900 $55,000

365

Ticker ACER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,100,000
Description
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.